Fariba Vaziri-Sani
1 – 39 of 39
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Evaluation of the RSR 3 screen ICA™ and 2 screen ICA™ as screening assays for type 1 diabetes in Sweden
(
- Contribution to journal › Article
- 2021
-
Mark
Neutralizing Ljungan virus antibodies in children with newly diagnosed type 1 diabetes
(
- Contribution to journal › Article
- 2017
-
Mark
Osteoprotegerin autoantibodies do not predict low bone mineral density in middle-aged women
(
- Contribution to journal › Article
-
Mark
Islet autoantibodies present in association with Ljungan virus infection in bank voles (Myodes glareolus) in northern Sweden
(
- Contribution to journal › Article
- 2015
-
Mark
Prospective evaluation of glutamine and phospholipids levels in first degree relatives of patients with Type 1 Diabetes from a multiethnic population.
(
- Contribution to journal › Article
-
Mark
Serological evaluation of possible exposure to Ljungan virus and related parechovirus in autoimmune (type 1) diabetes in children.
(
- Contribution to journal › Article
-
Mark
Doubly reactive INS-IGF2 autoantibodies in children with newly diagnosed autoimmune (type 1) diabetes.
(
- Contribution to journal › Article
-
Mark
Neuropeptide Y is a minor autoantigen in newly diagnosed type 1 diabetes patients.
(
- Contribution to journal › Article
-
Mark
ZnT8 autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody positive type 1 diabetes patients.
(
- Contribution to journal › Article
- 2014
-
Mark
Antibodies to islet cell autoantigens, rotaviruses and/or enteroviruses in cord blood and healthy mothers in relation to the 2010-2011 winter viral seasons in Israel: a pilot study
(
- Contribution to journal › Article
-
Mark
Association of TCF7L2 variation with single islet autoantibody expression in children with type 1 diabetes.
(
- Contribution to journal › Article
-
Mark
Zinc transporter 8 autoantibodies in patients with type 1 diabetes from a multiethnic population and their first degree relatives.
(
- Contribution to journal › Article
-
Mark
Loss-of-function mutations in SLC30A8 protect against type 2 diabetes.
(
- Contribution to journal › Article
- 2013
-
Mark
Relationship Between Ljungan Virus Antibodies, HLA-DQ8, and Insulin Autoantibodies in Newly Diagnosed Type 1 Diabetes Children
(
- Contribution to journal › Article
-
Mark
Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.
(
- Contribution to journal › Article
-
Mark
Neuropeptide Y autoantibodies in patients with long-term type 1 and type 2 diabetes and neuropathy.
(
- Contribution to journal › Article
-
Mark
Autoimmunity against INS-IGF2 expressed in human pancreatic islets.
(
- Contribution to journal › Article
- 2012
-
Mark
Zinc Transporter 8 Autoantibodies and Their Association With SLC30A8 and HLA-DQ Genes Differ Between Immigrant and Swedish Patients With Newly Diagnosed Type 1 Diabetes in the Better Diabetes Diagnosis Study.
(
- Contribution to journal › Article
-
Mark
Association between autoantibodies to the Arginine variant of the Zinc transporter 8 (ZnT8) and stimulated C-peptide levels in Danish children and adolescents with newly diagnosed type 1 diabetes
(
- Contribution to journal › Article
-
Mark
Islet autoantibodies and residual beta cell function in type 1 diabetes children followed for 3-6 years
(
- Contribution to journal › Article
-
Mark
Long-term sustained autoimmune response to beta cell specific zinc transporter (ZnT8, W, R, Q) in young adult patients with preserved beta cell function at diagnosis of diabetes.
2012) In Autoimmunity(
- Contribution to journal › Article
-
Mark
Antigenicity and epitope specificity of ZnT8 autoantibodies in type 1 diabetes.
2012) In Scandinavian Journal of Immunology(
- Contribution to journal › Article
-
Mark
DETECTION OF LACTOBACILLI IN MONTHLY MAIL-IN STOOL SAMPLES FROM 3-18 MONTHS OLD INFANTS AT GENETIC RISK FOR TYPE 1 DIABETES
(
- Contribution to journal › Article
- 2011
-
Mark
The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes.
(
- Contribution to journal › Article
-
Mark
Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes
(
- Contribution to journal › Article
-
Mark
Relationship between ZnT8Ab, the SLC30A8 gene and disease progression in children with newly diagnosed type 1 diabetes
(
- Contribution to journal › Article
-
Mark
Improved efficacy by using the pTnT-rhtTG plasmid for the detection of celiac disease specific tissue transglutaminase autoantibodies in radioligand binding assays.
(
- Contribution to journal › Article
-
Mark
A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes.
(
- Contribution to journal › Article
- 2010
-
Mark
Novel triples mix radio binding assay for the ZnT8 (ZnT8RWQ) autoantibody variants in children with newly diagnosed diabetes
2010) 46th Annual Meeting of the European-Association-for-the- Study-of-Diabetes (EASD) In Diabetologia 53(Suppl. 1). p.264-264(
- Contribution to journal › Published meeting abstract
-
Mark
Clinical and genetical characterisation of a series of patients with type 1 diabetes induced by interferon therapy
2010) 46th Annual Meeting of the European-Association-for-the- Study-of-Diabetes (EASD) In Diabetologia 53(Suppl. 1). p.273-273(
- Contribution to journal › Published meeting abstract
-
Mark
ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset.
(
- Contribution to journal › Article
- 2009
-
Mark
Strong association between SLC30A8 gene variant and ZnT8 autoantibody specificity during disease progression in two independent cohorts of children with newly diagnosed type 1 diabetes
2009) 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes In Diabetologia 52(Suppl 1). p.29-29(
- Contribution to journal › Published meeting abstract
-
Mark
ZnT8, GAD 65 and IA-2 autoantibodies in type 1 diabetes children at diagnosis and 3-5 years after the diagnosis, stratified for residual beta cell function
(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation.
(
- Contribution to journal › Article
- 2007
-
Mark
A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation.
(
- Contribution to journal › Article
- 2006
-
Mark
Platelet activation in hemolytic uremic syndrome.
(
- Contribution to journal › Scientific review
-
Mark
Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome.
(
- Contribution to journal › Article
-
Mark
Studies of the role of complement factor H in hemolytic uremic syndrome
2006) In Journal of thrombosis and haemostasis, and Kidney International(
- Thesis › Doctoral thesis (compilation)
- 2005
-
Mark
Factor H binds to washed human platelets
(
- Contribution to journal › Article